Newly Patented Compound Shows Promise In Treating Obesity

U.S. researchers have been awarded a patent for an antioxidant compound that, in mice, decreases obesity by breaking down triglycerides stored in fat tissue. The compound could someday be used to treat obesity and related disorders like type 2 diabetes in humans. According to the researchers, obese mice that ingested the compound lost 40 percent of their body weight. The next step is to figure out how the compound, MnTBAP, triggers cellular and molecular events that lead to the weight loss, the Skidmore College researchers say.